Pfizer says Covid shot 100% effective in adolescents after 4 months
The companies said that the new data, which involved 2,228 trial participants, will help support their applications for full approval in the United States and worldwide.

The companies said that the new data, which involved 2,228 trial participants, will help support their applications for full approval in the United States and worldwide.
Dr Ella also said they have almost completed phase two trials for the nasal vaccine and results of their vaccine for children were "extremely good".
First approved in the European Union in December 2020, Comirnaty COVID-19 vaccine is currently authorized for administration in people aged 12 and above.
If granted approval by DCGI, Covaxin will become only the second vaccine after Zydus Cadila's ZyCoV-D to be granted permission for inoculating children in 2-18 age group.
Vaccination of healthy children would commence next year, but the immunization of kids with comorbidities would start next month.
The government is planning to get children with comorbidities the vaccine by October or November. Children between the ages of 12 and 17, with comorbidities will be eligible for the Zydus Cadila shot. Zydus Cadila has three doses in its DNA based ZyCov-D vaccine.
Government has granted Emergency Use Authorisation (EUA) for the COVID-19 vaccines of Moderna and Johnson & Johnson for months now, still discussions are going on with these vaccine manufacturers to start their vaccine supplies
When asked about vaccines for kids, Adar Poonawalla said, "The Covovax vaccine for kids will be launched in the first quarter of the next year most likely in January-February."